Exact Mass: 632.2958

Phaeantharine

C39H40N2O6+2 (632.2886)

magnesium;3-[(3R,21S,22S)-11-ethyl-16-(1-hydroxyethyl)-3-methoxycarbonyl-12,17,21,26-tetramethyl-4-oxo-23,25-diaza-7,24-diazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13(25),14,16,18,20(23)-decaen-22-yl]propanoic acid

C35H36MgN4O6 (632.2485)

Bacteriochlorophyllide a

C35H36MgN4O6 (632.2485)

A chlorophyllide obtained by hydrolysis of the terpenoid ester moiety of bacteriochlorophyll a.

Coagulin R 3-glucoside

C34H48O11 (632.3196)

Coagulin R 3-glucoside is found in fruits. Coagulin R 3-glucoside is a constituent of Physalis peruviana (Cape gooseberry). Constituent of Physalis peruviana (Cape gooseberry). Coagulin R 3-glucoside is found in fruits.

Casokefamide

C33H40N6O7 (632.2958)

PA(8:0/PGE2)

C31H53O11P (632.3325)

PA(8:0/PGE2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGE2), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin E2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGE2/8:0)

C31H53O11P (632.3325)

PA(PGE2/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE2/8:0), in particular, consists of one chain of one Prostaglandin E2 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/PGD2)

C31H53O11P (632.3325)

PA(8:0/PGD2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGD2), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin D2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGD2/8:0)

C31H53O11P (632.3325)

PA(PGD2/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD2/8:0), in particular, consists of one chain of one Prostaglandin D2 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C31H53O11P (632.3325)

PA(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Lipoxin A4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0)

C31H53O11P (632.3325)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0), in particular, consists of one chain of one Lipoxin A4 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Amotsangin E

C36H40O10 (632.2621)

Ejap 5

C32H40O13 (632.2469)

Meliacarpinin B

C33H44O12 (632.2833)

16alpha-Acetoxyasclepin

C33H44O12 (632.2833)

Orthosiphol N

C36H40O10 (632.2621)

Dipsanoside G

C29H44O15 (632.268)

Ejap 4

C32H40O13 (632.2469)

Scutalpin L

C36H40O10 (632.2621)

Coagulin P

C34H48O11 (632.3196)

Dysinosin A

C26H44N6O10S (632.2839)

Woorenol

C32H40O13 (632.2469)

Tetrahydrogambogic acid

C38H48O8 (632.3349)

KBio2_000708

C38H48O8 (632.3349)

7(1)-Hydroxychlorophyllide a

C35H36MgN4O6+2 (632.2485)

Bacteriochlorophyllide b

C35H36MgN4O6+2 (632.2485)

dichrostachine E

C36H40O10 (632.2621)

Moritoside

C34H48O11 (632.3196)

trichilin G

C33H44O12 (632.2833)

aplysqualenol B

C31H53BrO8 (632.2924)

C29H44O15

C29H44O15 (632.268)

(5alpha,6alpha,7alpha,22R)-5-hydroxy-1,26-dioxo-6,7:22,26-diepoxyergosta-2,24-dien-27-yl beta-D-glucopyranoside|baimantuoluoside C

C34H48O11 (632.3196)

NSC333061

C33H44O12 (632.2833)

Myrtucommulone E

C38H48O8 (632.3349)

Picrajavanin A

C36H40O10 (632.2621)

5,6,7,10-Tetraacetoxy-5a-(acetoxymethyl)-4-(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin

C32H40O13 (632.2469)

Flindercarpin 2

C32H40O13 (632.2469)

MS000070186

C34H48O11 (632.3196)

C33H44O12

C33H44O12 (632.2833)

Rumphioside CI

C29H44O15 (632.268)

euonydin A-5

C32H40O13 (632.2469)

sitoindoside IX|sitoindoside-IX|sitoinoside IX

C34H48O11 (632.3196)

15-Acetoxy-2??,9??-di-(??-furancarbonyloxy)-4??,6??-dihydroxy-1??-(2-methylbutanoyloxy)-dihydro-??-agarofuran

C32H40O13 (632.2469)

Euphoppin B

C34H48O11 (632.3196)

20-O-benzoyl-12-O-cinnamoyl-3beta,5alpha,8beta,12beta,14beta,17beta,20-heptahydroxy-(20S)-pregn-6-ene

C37H44O9 (632.2985)

petuniasterone I

C34H48O9S (632.3019)

((aR,5R,6S,7R,8R)-5,6,7,8-tetrahydro-1,12-dihydroxy-2,3,10,11-tetramethoxy-6,7-dimethyl-5-[((E)-3-phenylprop-2-enoyl)oxy]dibenzo[a,c]cycloocten-5-yl) (Z)-2-methylbut-2-enoate|renchangianin C

C36H40O10 (632.2621)

6,7,10-Triacetoxy-5-(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-5a-(2-methylbutanoyloxymethyl)-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-9-ol

C33H44O12 (632.2833)

trigonothyrin B

C36H40O10 (632.2621)

flindercarpin-2

C32H40O13 (632.2469)

DTXSID90964460

C34H48O11 (632.3196)

SCUTEBATA A

C36H40O10 (632.2621)

6alpha-acetoxy-9beta-benzoyloxy-1beta-cinnamoyloxy-8beta-butanoyloxy-beta-dihydroagarofuran|6??-Acetoxy-9??-benzoyloxy-1??-cinnamoyloxy-8??-butanoyloxy-??-dihydroagarofuran

C37H44O9 (632.2985)

5,7,3,4-tetrahydroxy-6-(2-undecanonyl)-3-O-beta-D-galactopyranosyl flavonoid|houttuynoid E

C32H40O13 (632.2469)

5,7,3,4-tetrahydroxy-2-(2-undecanonyl)-3-O-beta-D-galactopyranosyl flavonoid|houttuynoid D

C32H40O13 (632.2469)

yuanhuajine

C37H44O9 (632.2985)

aphanalide D

C34H48O11 (632.3196)

aphanalide E

C34H48O11 (632.3196)

aphanagranin D

C33H44O12 (632.2833)

aphanalide C

C34H48O11 (632.3196)

6alpha,8alpha,9beta,13-tetraacetoxy-1beta-cinnamoyloxy-2beta,4alpha-dihydroxy-beta-dihydroagarofuran

C32H40O13 (632.2469)

walsogyne E

C34H48O11 (632.3196)

7alpha-acetoxy-2alpha,3alpha-dibenzoyloxy-1alpha,8beta-dihydroxyisopimar-15-ene-11,14-dione|orthoarisin C

C36H40O10 (632.2621)

NCI60_039302

C34H48O11 (632.3196)

20,27-dihydroxy-3beta-(O-beta-D-glucopyranosyl)-1-oxo-(20S,22R)-witha-5,14,24-trienolide|coagulin P

C34H48O11 (632.3196)

7,10-Diacetoxy-5a-(acetoxymethyl)-5-(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-6-(2-methylbutanoyloxy)-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-9-ol

C33H44O12 (632.2833)

6,10-Diacetoxy-5a-(acetoxymethyl)-5-(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-4-(2-methylbutanoyloxy)-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-9-ol

C33H44O12 (632.2833)

MS000176795

C34H48O11 (632.3196)

scupolin C

C36H40O10 (632.2621)

(2R,5S,6S,7R,8R,9R,10S,12S,18R,19S)-18,19-diacetoxy-18,19-epoxy-2,7-dihydroxy-6-[(2Z,4E)-decadienoyloxy]-12-hydroperoxycleroda-3,13(16),14-triene|argutin H

C34H48O11 (632.3196)

4,6,7,10-Tetraacetoxy-5a-(acetoxymethyl)-5-(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin

C32H40O13 (632.2469)

(2R,5S,6S,7R,8R,9R,10S,12S,18R,19S)-18,19-diacetoxy-18,19-epoxy-2-[(2Z,4E)-decadienoyloxy]-6,7-dihydroxy-12-hydroperoxycleroda-3,13(16),14-triene|argutin G

C34H48O11 (632.3196)

Orthosiphonone D

C36H40O10 (632.2621)

benzyl 2-O-methylmicrophyllinate

C37H44O9 (632.2985)

Petuniasterone P3

C34H48O9S (632.3019)

Xyloccensin J

C33H44O12 (632.2833)

Woorenoside V

C32H40O13 (632.2469)

Methyl hexa(alpha-hydrocyisovalerate)

C31H52O13 (632.3408)

Petuniasterone P4

C34H48O9S (632.3019)

Tasumatrol F

C33H44O12 (632.2833)

A taxane diterpenoid isolated from Taxus sumatrana and has been shown to exhibit antineoplastic activity.

Leu Ala Met Glu Arg

C26H48N8O8S (632.3316)

Tetrahydrogambogic Acid_major

C38H48O8 (632.3349)

Tetrahydrogambogic Acid_minor

C38H48O8 (632.3349)

Glu Ile Trp Trp

C33H40N6O7 (632.2958)

Glu Leu Trp Trp

C33H40N6O7 (632.2958)

Glu Trp Ile Trp

C33H40N6O7 (632.2958)

Glu Trp Leu Trp

C33H40N6O7 (632.2958)

Glu Trp Trp Ile

C33H40N6O7 (632.2958)

Glu Trp Trp Leu

C33H40N6O7 (632.2958)

His Lys Trp Tyr

C32H40N8O6 (632.3071)

His Lys Tyr Trp

C32H40N8O6 (632.3071)

His Gln Trp Tyr

C31H36N8O7 (632.2707)

His Gln Tyr Trp

C31H36N8O7 (632.2707)

His Trp Lys Tyr

C32H40N8O6 (632.3071)

His Trp Gln Tyr

C31H36N8O7 (632.2707)

His Trp Tyr Lys

C32H40N8O6 (632.3071)

His Trp Tyr Gln

C31H36N8O7 (632.2707)

His Tyr Lys Trp

C32H40N8O6 (632.3071)

His Tyr Gln Trp

C31H36N8O7 (632.2707)

His Tyr Trp Lys

C32H40N8O6 (632.3071)

His Tyr Trp Gln

C31H36N8O7 (632.2707)

Ile Glu Trp Trp

C33H40N6O7 (632.2958)

Ile Trp Glu Trp

C33H40N6O7 (632.2958)

Ile Trp Trp Glu

C33H40N6O7 (632.2958)

Lys His Trp Tyr

C32H40N8O6 (632.3071)

Lys His Tyr Trp

C32H40N8O6 (632.3071)

Lys Asn Trp Trp

C32H40N8O6 (632.3071)

Lys Trp His Tyr

C32H40N8O6 (632.3071)

Lys Trp Asn Trp

C32H40N8O6 (632.3071)

Lys Trp Trp Asn

C32H40N8O6 (632.3071)

Lys Trp Tyr His

C32H40N8O6 (632.3071)

Lys Tyr His Trp

C32H40N8O6 (632.3071)

Lys Tyr Trp His

C32H40N8O6 (632.3071)

Leu Glu Trp Trp

C33H40N6O7 (632.2958)

Leu Trp Glu Trp

C33H40N6O7 (632.2958)

Leu Trp Trp Glu

C33H40N6O7 (632.2958)

Asn Lys Trp Trp

C32H40N8O6 (632.3071)

Asn Gln Trp Trp

C31H36N8O7 (632.2707)

Asn Trp Lys Trp

C32H40N8O6 (632.3071)

Asn Trp Gln Trp

C31H36N8O7 (632.2707)

Asn Trp Trp Lys

C32H40N8O6 (632.3071)

Asn Trp Trp Gln

C31H36N8O7 (632.2707)

Gln His Trp Tyr

C31H36N8O7 (632.2707)

Gln His Tyr Trp

C31H36N8O7 (632.2707)

Gln Asn Trp Trp

C31H36N8O7 (632.2707)

Gln Trp His Tyr

C31H36N8O7 (632.2707)

Gln Trp Asn Trp

C31H36N8O7 (632.2707)

Gln Trp Trp Asn

C31H36N8O7 (632.2707)

Gln Trp Tyr His

C31H36N8O7 (632.2707)

Gln Tyr His Trp

C31H36N8O7 (632.2707)

Gln Tyr Trp His

C31H36N8O7 (632.2707)

Trp Glu Ile Trp

C33H40N6O7 (632.2958)

Trp Glu Leu Trp

C33H40N6O7 (632.2958)

Trp Glu Trp Ile

C33H40N6O7 (632.2958)

Trp Glu Trp Leu

C33H40N6O7 (632.2958)

Trp His Lys Tyr

C32H40N8O6 (632.3071)

Trp His Gln Tyr

C31H36N8O7 (632.2707)

Trp His Tyr Lys

C32H40N8O6 (632.3071)

Trp His Tyr Gln

C31H36N8O7 (632.2707)

Trp Ile Glu Trp

C33H40N6O7 (632.2958)

Trp Ile Trp Glu

C33H40N6O7 (632.2958)

Trp Lys His Tyr

C32H40N8O6 (632.3071)

Trp Lys Asn Trp

C32H40N8O6 (632.3071)

Trp Lys Trp Asn

C32H40N8O6 (632.3071)

Trp Lys Tyr His

C32H40N8O6 (632.3071)

Trp Leu Glu Trp

C33H40N6O7 (632.2958)

Trp Leu Trp Glu

C33H40N6O7 (632.2958)

Trp Asn Lys Trp

C32H40N8O6 (632.3071)

Trp Asn Gln Trp

C31H36N8O7 (632.2707)

Trp Asn Trp Lys

C32H40N8O6 (632.3071)

Trp Asn Trp Gln

C31H36N8O7 (632.2707)

Trp Gln His Tyr

C31H36N8O7 (632.2707)

Trp Gln Asn Trp

C31H36N8O7 (632.2707)

Trp Gln Trp Asn

C31H36N8O7 (632.2707)

Trp Gln Tyr His

C31H36N8O7 (632.2707)

Trp Trp Glu Ile

C33H40N6O7 (632.2958)

Trp Trp Glu Leu

C33H40N6O7 (632.2958)

Trp Trp Ile Glu

C33H40N6O7 (632.2958)

Trp Trp Lys Asn

C32H40N8O6 (632.3071)

Trp Trp Leu Glu

C33H40N6O7 (632.2958)

Trp Trp Asn Lys

C32H40N8O6 (632.3071)

Trp Trp Asn Gln

C31H36N8O7 (632.2707)

Trp Trp Gln Asn

C31H36N8O7 (632.2707)

Trp Tyr His Lys

C32H40N8O6 (632.3071)

Trp Tyr His Gln

C31H36N8O7 (632.2707)

Trp Tyr Lys His

C32H40N8O6 (632.3071)

Trp Tyr Gln His

C31H36N8O7 (632.2707)

Tyr His Lys Trp

C32H40N8O6 (632.3071)

Tyr His Gln Trp

C31H36N8O7 (632.2707)

Tyr His Trp Lys

C32H40N8O6 (632.3071)

Tyr His Trp Gln

C31H36N8O7 (632.2707)

Tyr Lys His Trp

C32H40N8O6 (632.3071)

Tyr Lys Trp His

C32H40N8O6 (632.3071)

Tyr Gln His Trp

C31H36N8O7 (632.2707)

Tyr Gln Trp His

C31H36N8O7 (632.2707)

Tyr Trp His Lys

C32H40N8O6 (632.3071)

Tyr Trp His Gln

C31H36N8O7 (632.2707)

Tyr Trp Lys His

C32H40N8O6 (632.3071)

Tyr Trp Gln His

C31H36N8O7 (632.2707)

RESLE

C25H44N8O11 (632.3129)

Coagulin R 3-glucoside

C34H48O11 (632.3196)

3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[ 5.5]undecane (PEP-36)

C35H54O6P2 (632.3395)

ortho-hydroxy atorvastatin

C33H38FN2NaO8 (632.251)

(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate

C34H49F5O3S (632.3322)

Locicortolone

C36H50Cl2O5 (632.3035)

[D-Ala2,4,Tyr5] -b-Casomorphin (1-5)

C33H40N6O7 (632.2958)

Phenyl2,3,4,6-tetra-O-benzyl-b-D-thiogalactopyranoside

C40H40O5S (632.2596)

Bis[4-(9,9-diMethyl-9,10-dihydroacridine)phenyl]solfone

C42H36N2O2S (632.2497)

Sitoindoside IX

C34H48O11 (632.3196)

A withanolide saponin that consists of withaferin A attached to a beta-D-glucopyranosyl residue at position 27 via a glycosidic linkage. Isolated from Physalis longifolia, it exhibits antineoplastic activity.

1-{3-Methyl-2-[4-(morpholine-4-carbonyl)-benzoylamino]-butyryl}-pyrrolidine-2-carboxylic acid (3,3,4,4,4-pentafluoro-1-isopropyl-2-oxo-butyl)-amide

C29H37F5N4O6 (632.2633)

Ajugamarin H1

C34H48O11 (632.3196)

A diterpene lactone isolated from the whole plants of Ajuga ciliata.

ajugamarin G1

C34H48O11 (632.3196)

A diterpene lactone isolated from the whole plant of Ajuga ciliata.

Losalen

C34H42F2O9 (632.2797)

D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

Mdl 101,146

C29H37F5N4O6 (632.2633)

Methanofuran b

C29H38N5O11- (632.2568)

(31R)-8,12-diethyl-71,71-dihydroxybacteriochlorophyllide c

C35H36MgN4O6-2 (632.2485)

O-methyl-4-O-[2,4-di-O-methyl-alpha-L-fucopyranosyl-(1->3)-alpha-L-rhamnopyranosyl-(1->3)-2-O-methyl-alpha-L-rhamnopyranosyl]-hydroxybenzoate

C29H44O15 (632.268)

3-Hydroxyethylbacteriochlorophyllide

C35H36MgN4O6-2 (632.2485)

Arbekacin 2-phosphate

C22H45N6O13P (632.2782)

PA(8:0/PGE2)

C31H53O11P (632.3325)

PA(PGE2/8:0)

C31H53O11P (632.3325)

PA(8:0/PGD2)

C31H53O11P (632.3325)

PA(PGD2/8:0)

C31H53O11P (632.3325)

PA(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C31H53O11P (632.3325)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0)

C31H53O11P (632.3325)

2-[[(2R)-3-acetyloxy-2-[(5R,6R,7Z,9Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H51NO11P+ (632.32)

2-[[(2R)-2-acetyloxy-3-[(5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H51NO11P+ (632.32)

Dinoxin B

C34H48O11 (632.3196)

A natural product found in Datura inoxia.

Argutin H

C34H48O11 (632.3196)

A natural product found in Casearia arguta.

Argutin G

C34H48O11 (632.3196)

A natural product found in Casearia arguta.

1-[[(2R,3R)-10-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C30H35F3N6O6 (632.257)

Smgdg O-18:5_3:0

C30H48O12S (632.2866)

[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C29H45O13P (632.2598)

3-(1-hydroxyethyl)chlorophyllide a

C35H36MgN4O6 (632.2485)

A chlorophyllide obtained by hydrolysis of the terpenoid ester moiety of 3-(1-hydroxyethyl)chlorophyll a.

3-(1-hydroxyethyl)bacteriochlorophyllide a(2-)

C35H36MgN4O6 (632.2485)

A cyclic tetrapyrrole anion that is obtained from 3-(1-hydroxyethyl)bacteriochlorophyllide a via deprotonation of the carboxy group and formation of a carbide ion. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

SMGDG O-21:5

C30H48O12S (632.2866)

SQDG 20:5;O

C29H44O13S (632.2502)

SQDG 21:4

C30H48O12S (632.2866)

DGMG 15:4

C30H48O14 (632.3044)

SQMG 22:4

C31H52O11S (632.323)

DGGA 25:7

C34H48O11 (632.3196)

PA 16:1/12:3;O3

C31H53O11P (632.3325)

PA 20:1/8:3;O3

C31H53O11P (632.3325)

PA 20:2/8:2;O3

C31H53O11P (632.3325)

PA 28:4;O3

C31H53O11P (632.3325)

LPGP O-22:1

C28H58O11P2 (632.3454)

LPGP P-22:0

C28H58O11P2 (632.3454)

PG O-25:5;O2

C31H53O11P (632.3325)

PG P-16:0/9:4;O2

C31H53O11P (632.3325)

PG P-18:1/7:3;O2

C31H53O11P (632.3325)

PG 18:1/7:3;O

C31H53O11P (632.3325)

PG 20:3/5:1;O

C31H53O11P (632.3325)

PG 20:4/4:1;O2

C30H49O12P (632.2961)

PG 24:5;O2

C30H49O12P (632.2961)

PG 25:4;O

C31H53O11P (632.3325)

ST 24:1;O8;GlcA

C30H48O14 (632.3044)

ST 25:0;O7;GlcA

C31H52O13 (632.3408)

ST 26:7;O7;GlcA

C32H40O13 (632.2469)

ST 27:6;O6;GlcA

C33H44O12 (632.2833)

ST 28:5;O5;GlcA

C34H48O11 (632.3196)

ST 25:1;O8;Hex

C31H52O13 (632.3408)

ST 27:7;O7;Hex

C33H44O12 (632.2833)

ST 28:6;O6;Hex

C34H48O11 (632.3196)

14-(acetyloxy)-6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-18-yl 2-methylpropanoate

C33H44O12 (632.2833)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2z,4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-5-{2-[(2-methylbutanoyl)oxy]-2-(5-oxo-2h-furan-3-yl)ethyl}-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl 2-methylbut-2-enoate

C34H48O11 (632.3196)

(6r,14r)-13-hydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6,14-dihydro-5,11-dioxapentaphene-1,3,7,9-tetrone

C38H48O8 (632.3349)

(1r,4ar,5s,6s,8s,8ar)-5-[(1s)-1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-8-(benzoyloxy)-6-hydroxy-5,6-dimethyl-hexahydrospiro[naphthalene-1,2'-oxiran]-8a-ylmethyl benzoate

C36H40O10 (632.2621)

(1s,2r,4s,5r,6s,7s,8r,9r,12r)-4,5,8,12-tetrakis(acetyloxy)-6-[(acetyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C32H40O13 (632.2469)

(1s,2r,4r,5r,6s,8r,10s,11s,12r,14r,15s,19r,20r,21s)-20-(acetyloxy)-6-(furan-3-yl)-4,12,19,21-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate

C33H44O12 (632.2833)

methyl (2r,4ar,6r,6as,10ar,10bs)-2-[(2s,3s,4s,5s)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]-6a,10b-dimethyl-4-oxo-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate

C29H44O15 (632.268)

6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2,12-dihydroxy-2,10,10-trimethyl-5-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl furan-3-carboxylate

C32H40O13 (632.2469)

(3s,4r,4ar,6s,7r,7ar)-3-hydroxy-4-(methoxycarbonyl)-7-methyl-octahydrocyclopenta[c]pyran-6-yl (4s,5s,6s)-4-(2,2-dimethoxyethyl)-5-ethenyl-6-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C29H44O15 (632.268)

methyl 2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)-6a,10b-dimethyl-4-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate

C29H44O15 (632.268)

5-{[8a-(5,7-dihydroxy-4-oxochromen-2-yl)-6-methoxy-2-methyl-5,8-dioxo-4,4a-dihydro-1h-naphthalen-1-yl]methyl}-7-hydroxy-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C36H40O10 (632.2621)

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-5-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

(1s,3s,4s,5r,6r,7r)-1-[(3e)-3,5-dimethyl-6-phenylhex-3-en-1-yl]-6-{[(2e,4s,6s)-4,6-dimethyloct-2-enoyl]oxy}-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C33H44O12 (632.2833)

12-deacetyltrichilin i

C33H44O12 (632.2833)

{"Ingredient_id": "HBIN000775","Ingredient_name": "12-deacetyltrichilin i","Alias": "NA","Ingredient_formula": "C33H44O12","Ingredient_Smile": "NA","Ingredient_weight": "632.703","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9367","PubChem_id": "NA","DrugBank_id": "NA"}

15-acetoxy-2α,9β-di-(β-furancarbonyloxy)-4β,6β-dihydroxy-1α-(2-methylbutanoyloxy)-dihydro-β-agarofuran

C32H40O13 (632.2469)

{"Ingredient_id": "HBIN001601","Ingredient_name": "15-acetoxy-2\u03b1,9\u03b2-di-(\u03b2-furancarbonyloxy)-4\u03b2,6\u03b2-dihydroxy-1\u03b1-(2-methylbutanoyloxy)-dihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C32H40O13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "160","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

1-deoxy-11-methoxy-3- tigloyloxymeliacarpinin

C33H44O12 (632.2833)

{"Ingredient_id": "HBIN002474","Ingredient_name": "1-deoxy-11-methoxy-3- tigloyloxymeliacarpinin","Alias": "NA","Ingredient_formula": "C33H44O12","Ingredient_Smile": "NA","Ingredient_weight": "632.703","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9220","PubChem_id": "NA","DrugBank_id": "NA"}

6α-acetoxy-9β-benzoyloxy-1β-cinnamoyloxy-8β-butanoyloxy-β-dihydroagarofuran

C37H44O9 (632.2985)

{"Ingredient_id": "HBIN012195","Ingredient_name": "6\u03b1-acetoxy-9\u03b2-benzoyloxy-1\u03b2-cinnamoyloxy-8\u03b2-butanoyloxy-\u03b2-dihydroagarofuran","Alias": "NA","Ingredient_formula": "C37H44O9","Ingredient_Smile": "CCCC(=O)OC1C2C(C3(C(CCC(C3(C1OC(=O)C4=CC=CC=C4)C)OC(=O)C=CC5=CC=CC=C5)C)OC2(C)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "131","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

6″-O-trans-sinapoylgenipin gentiobioside

C34H48O11 (632.3196)

{"Ingredient_id": "HBIN012724","Ingredient_name": "6\u2033-O-trans-sinapoylgenipin gentiobioside","Alias": "NA","Ingredient_formula": "C34H48O11","Ingredient_Smile": "CC1C(C(C(OC1COC2C(C(C(C(O2)CO)O)O)O)OC(=O)C(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=O)C)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40184","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,2r,4r,5s,6r,8r,10s,11s,12s,14r,15r,16s,19r,20s,21r)-21-(acetyloxy)-6-(furan-3-yl)-4,12,19,20-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl (2r)-2-methylbutanoate

C33H44O12 (632.2833)

(2s,3s,4r,4as,4br,7r,8ar,9r,10as)-3-(acetyloxy)-4-(benzoyloxy)-7-ethenyl-8a,9-dihydroxy-1,1,4a,7-tetramethyl-5,8-dioxo-octahydrophenanthren-2-yl benzoate

C36H40O10 (632.2621)

(6r)-6-[(1r)-1-[(1s,3br,7s,9ar,9bs,11ar)-9a,11a-dimethyl-9-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3bh,4h,5h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H48O11 (632.3196)

(1r,3s,4r)-1-[(1s)-1,2-dihydroxyethyl]-3-{4-[2-hydroxy-4-(3-hydroxypropyl)-6-methoxyphenoxy]-3,5-dimethoxyphenyl}-4-(hydroxymethyl)-7,9-dimethoxy-2-oxaspiro[4.5]deca-6,9-dien-8-one

C32H40O13 (632.2469)

methyl (1s,2r,7s,8s,9r)-8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-2,8-dimethyl-10-oxo-11-oxatricyclo[7.2.1.0²,⁷]dodec-3-ene-3-carboxylate

C29H44O15 (632.268)

4,5,12-tris(acetyloxy)-2-hydroxy-2,10,10-trimethyl-6-{[(2-methylbutanoyl)oxy]methyl}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

(1s,3r,5r,6as,7s,8s,9r,10s,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2e,4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

5-(acetyloxy)-3-(furan-3-yl)-6-[3-(2-methoxy-2-oxoethyl)-2,2,4-trimethyl-7-oxo-3h-oxepin-4-yl]-3a-methyl-7-methylidene-hexahydroindeno[1,7a-b]oxiren-4-yl benzoate

C36H40O10 (632.2621)

(1s,2r,4s,5r,6s,7s,8r,9r,12r)-4,5,7,12-tetrakis(acetyloxy)-6-[(acetyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C32H40O13 (632.2469)

[3,4-bis(acetyloxy)-5-hydroxy-6-[4-hydroxy-5-methyl-2-(3,7,11-trimethyl-9-oxododeca-2,6-dien-1-yl)phenoxy]oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

methyl 2-(acetyloxy)-2-[7,8-bis(acetyloxy)-5-(furan-3-yl)-6,10,12,12,14-pentamethyl-16-methylidene-3-oxo-4,13,15-trioxatetracyclo[7.6.1.0¹,⁶.0¹⁰,¹⁴]hexadecan-11-yl]acetate

C32H40O13 (632.2469)

(4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-5-[(2s)-2-{[(2s)-2-methylbutanoyl]oxy}-2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)

[3,4-bis(acetyloxy)-5-hydroxy-6-[4-hydroxy-2-(9-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-5-methylphenoxy]oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

(2r)-1-[(1s,2s,3'r,3as,3bs,4r,4'r,9ar,9br,11as)-4-(acetyloxy)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-3,3a,3b,4,5,9b,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxetan]-4'-yl]-3-hydroxy-2,3-dimethylbutan-2-yl 3-(methylsulfanyl)-3-oxopropanoate

C34H48O9S (632.3019)

(1s,2r,4s,5r,6s,7r,8r,9r,12r)-4,5,8,12-tetrakis(acetyloxy)-6-[(acetyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C32H40O13 (632.2469)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-9,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2z,4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

(1s,2s,5s,6s,7s,8r,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-8-{[(2r)-2-methylbutanoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

(1r,4ar,5s,6r,7s,8r,8ar)-8a-[(acetyloxy)methyl]-7-(benzoyloxy)-6-hydroxy-5,6-dimethyl-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydrospiro[naphthalene-1,2'-oxiran]-8-yl benzoate

C36H40O10 (632.2621)

(1r,2r,3r,4s,5s,7r,8r,9r,10r,11s,13s,15r)-2,4-bis(acetyloxy)-8,16-dihydroxy-5,9,12,12-tetramethyl-7-{[(2e)-2-methylbut-2-enoyl]oxy}-17-oxapentacyclo[7.6.2.0¹,¹⁰.0³,⁷.0¹¹,¹³]heptadecan-15-yl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)

[(2r,3s,4r,5r,6s)-3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-2-[(2e,6e,9r)-9-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-5-methylphenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

(2s,3r,5r)-5-[(1r)-1-[(2s,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-hydroxyethyl]-2-[(3r)-5-hydroxy-3-methoxy-4-methylidenepentyl]-2-methyloxolan-3-ol

C31H53BrO8 (632.2924)

(2s,3s,4r,5s,6r)-5-(acetyloxy)-6-{[(1r,3s,5s,7s,10s,11r,14r,15r,18r)-18-hydroxy-10,14-dimethyl-15-(5-oxo-2h-furan-3-yl)-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl acetate

C34H48O11 (632.3196)

(1r,4ar,5r,6r,7s,8r,8ar)-8a-[(acetyloxy)methyl]-7-(benzoyloxy)-6-hydroxy-5,6-dimethyl-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydrospiro[naphthalene-1,2'-oxiran]-8-yl benzoate

C36H40O10 (632.2621)

4-[1-(acetyloxy)-2-(4-hydroxy-5-oxo-2h-furan-3-yl)ethyl]-2-(benzoyloxy)-3-hydroxy-3,4,8,8a-tetramethyl-2,4a,5,6-tetrahydro-1h-naphthalen-1-yl benzoate

C36H40O10 (632.2621)

(1s)-2-[(4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-{[(2s)-2-methylbutanoyl]oxy}-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)

6-[1-(9a,11a-dimethyl-9-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H48O11 (632.3196)

6-hydroxy-2,16-dimethyl-15-{1-[4-methyl-6-oxo-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydropyran-2-yl]ethyl}-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one

C34H48O11 (632.3196)

3-[4-(acetyloxy)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-3,3a,3b,4,5,9b,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxetan]-4'-ylmethyl]-3-hydroxy-2-methylbutan-2-yl 3-(methylsulfanyl)-3-oxopropanoate

C34H48O9S (632.3019)

[3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-2-[(2e,6e,9s)-9-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-5-methylphenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

(3r)-3-[(1s,2s,3'r,3as,3bs,4r,4'r,9ar,9bs,11as)-4-(acetyloxy)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-3,3a,3b,4,5,9b,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxetan]-4'-ylmethyl]-3-hydroxy-2-methylbutan-2-yl 3-(methylsulfanyl)-3-oxopropanoate

C34H48O9S (632.3019)

6,8-bis(acetyloxy)-5-[(acetyloxy)methyl]-2,4,10-trihydroxy-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-2h,3h,4h,4ah,5h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl benzoate

C33H44O12 (632.2833)

(6r)-6-[(1r)-1-[(1s,3br,7r,9ar,9bs,11ar)-9a,11a-dimethyl-9-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H48O11 (632.3196)

3-(acetyloxy)-4-(benzoyloxy)-7-ethenyl-8a,9-dihydroxy-1,1,4a,7-tetramethyl-5,8-dioxo-octahydrophenanthren-2-yl benzoate

C36H40O10 (632.2621)

methyl (2s,4ar,6r,6ar,10as,10bs)-2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)-6a,10b-dimethyl-4-oxo-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate

C29H44O15 (632.268)

(1s,2s,4s,6r,7s,9r,13s,14r,15s,16s,17s)-4-(benzoyloxy)-15-methoxy-2,6,14,17-tetramethyl-3,11-dioxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-16-yl 2h-1,3-benzodioxole-5-carboxylate

C36H40O10 (632.2621)

4-[(benzyloxy)carbonyl]-3-methoxy-5-(2-oxoheptyl)phenyl 2-hydroxy-4-methoxy-6-(2-oxoheptyl)benzoate

C37H44O9 (632.2985)

methyl (2s)-2-(acetyloxy)-2-[(1s,5s,6r,7r,8r,9s,10r,11s,14r)-7,8-bis(acetyloxy)-5-(furan-3-yl)-6,10,12,12,14-pentamethyl-16-methylidene-3-oxo-4,13,15-trioxatetracyclo[7.6.1.0¹,⁶.0¹⁰,¹⁴]hexadecan-11-yl]acetate

C32H40O13 (632.2469)

4-(benzoyloxy)-15-methoxy-2,6,14,17-tetramethyl-3,11-dioxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-16-yl 2h-1,3-benzodioxole-5-carboxylate

C36H40O10 (632.2621)

[3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-5-methyl-2-[(2e,6e)-3,7,11-trimethyl-9-oxododeca-2,6-dien-1-yl]phenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

(1s,3r,5s,7r,9s,10s,12r,14r,15s,18r,19r,20r,22s,23r)-9-(acetyloxy)-14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-20-yl acetate

C33H44O12 (632.2833)

methyl 7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-23-[(2-methylbut-2-enoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C33H44O12 (632.2833)

8a-[(acetyloxy)methyl]-7-(benzoyloxy)-6-hydroxy-5,6-dimethyl-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydrospiro[naphthalene-1,2'-oxiran]-8-yl benzoate

C36H40O10 (632.2621)

(1s,2r,5s,6s,7s,8r,9r,12r)-12-(acetyloxy)-8-(butanoyloxy)-2,6,10,10-tetramethyl-5-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C37H44O9 (632.2985)

(1s,2s,4s,5r,10r,11s,14r,15r,18s)-5-hydroxy-10,14-dimethyl-15-[(1s)-1-[(2r)-4-methyl-6-oxo-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydropyran-2-yl]ethyl]-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C34H48O11 (632.3196)

(1s)-2-[(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-{[(2r)-2-methylbutanoyl]oxy}-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)

(1s,2r,4r,5r,6s,8r,10s,11s,12r,14r,15s,19r,20r,21s)-21-(acetyloxy)-6-(furan-3-yl)-4,12,19,20-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate

C33H44O12 (632.2833)

5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-8-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

(8r,9r,10s,11r)-3,16-dihydroxy-4,5,14,15-tetramethoxy-9,10-dimethyl-11-{[(2e)-3-phenylprop-2-enoyl]oxy}tricyclo[10.4.0.0²,⁷]hexadeca-1(12),2,4,6,13,15-hexaen-8-yl (2z)-2-methylbut-2-enoate

C36H40O10 (632.2621)

methyl 8,12,18-tris(acetyloxy)-6-(furan-3-yl)-9,14-dihydroxy-1,7,11,15-tetramethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecane-15-carboxylate

C33H44O12 (632.2833)

12-(acetyloxy)-8-(butanoyloxy)-2,6,10,10-tetramethyl-5-[(3-phenylprop-2-enoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C37H44O9 (632.2985)

(1s,3r,5r,6as,7s,8s,9r,10s,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-9,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2z,4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

1,3-bis(acetyloxy)-7-(2-hydroperoxy-3-methylidenepent-4-en-1-yl)-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl deca-2,4-dienoate

C34H48O11 (632.3196)

5-hydroxy-10,14-dimethyl-15-{1-[4-methyl-6-oxo-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydropyran-2-yl]ethyl}-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C34H48O11 (632.3196)

5-(acetyloxy)-6-{[18-hydroxy-10,14-dimethyl-15-(5-oxo-2h-furan-3-yl)-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl acetate

C34H48O11 (632.3196)

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

(1s,2r,6r,8r,10r,11s,12s,15r,16s)-15-hydroxy-2,16-dimethyl-5-oxo-15-[(1r)-1-[(1s,3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-3-en-10-yl acetate

C34H48O9S (632.3019)

6-[(acetyloxy)methyl]-5-(furan-3-carbonyloxy)-2,12-dihydroxy-2,10,10-trimethyl-4-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl furan-3-carboxylate

C32H40O13 (632.2469)

4,5,7,12-tetrakis(acetyloxy)-6-[(acetyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C32H40O13 (632.2469)

n-[(2s)-1-oxo-1-{[(8z,10z,16z)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl]benzenecarboximidic acid

C36H44N2O8 (632.3098)

(1s,3s,5s,7r,9r,10s,12s,14s,15r,18s,19s,20s,22r,23r)-9-(acetyloxy)-14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-20-yl acetate

C33H44O12 (632.2833)

(1s,2r,4s,5r,6s,8r,10s,11s,12r,14r,15r,16r,19r,20r,21s)-21-(acetyloxy)-6-(furan-3-yl)-4,12,19,20-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl (2r)-2-methylbutanoate

C33H44O12 (632.2833)

1,3-bis(acetyloxy)-7-(2-hydroperoxy-3-methylidenepent-4-en-1-yl)-9,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl deca-2,4-dienoate

C34H48O11 (632.3196)

(1s,2s,4s,5r,6r,7s,9r,12r)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2,12-dihydroxy-2,10,10-trimethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl furan-3-carboxylate

C32H40O13 (632.2469)

2-[8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-[(2-methylbutanoyl)oxy]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl 2-methylbut-2-enoate

C34H48O11 (632.3196)

[(2r,3s,4r,5r,6s)-3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-5-methyl-2-[(2e,6e)-3,7,11-trimethyl-9-oxododeca-2,6-dien-1-yl]phenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

1-[4-(acetyloxy)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-3,3a,3b,4,5,9b,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxetan]-4'-yl]-3-hydroxy-2,3-dimethylbutan-2-yl 3-(methylsulfanyl)-3-oxopropanoate

C34H48O9S (632.3019)

(1ar,3s,3ar,4r,5r,6r,7as)-5-(acetyloxy)-3-(furan-3-yl)-6-[(3r,4s)-3-(2-methoxy-2-oxoethyl)-2,2,4-trimethyl-7-oxo-3h-oxepin-4-yl]-3a-methyl-7-methylidene-hexahydroindeno[1,7a-b]oxiren-4-yl benzoate

C36H40O10 (632.2621)

(1s,2s,4s,5r,6r,7s,9r,12r)-4,5,12-tris(acetyloxy)-2-hydroxy-2,10,10-trimethyl-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

4,5,8,12-tetrakis(acetyloxy)-6-[(acetyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C32H40O13 (632.2469)

9-(acetyloxy)-14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-20-yl acetate

C33H44O12 (632.2833)

5-{1-[6-(5-bromo-2,6,6-trimethyloxan-2-yl)-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-hydroxyethyl}-2-(5-hydroxy-3-methoxy-4-methylidenepentyl)-2-methyloxolan-3-ol

C31H53BrO8 (632.2924)

1-(1,2-dihydroxyethyl)-3-{4-[2-hydroxy-4-(3-hydroxypropyl)-6-methoxyphenoxy]-3,5-dimethoxyphenyl}-4-(hydroxymethyl)-7,9-dimethoxy-2-oxaspiro[4.5]deca-6,9-dien-8-one

C32H40O13 (632.2469)

15-hydroxy-2,16-dimethyl-5-oxo-15-(1-{5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-3-en-10-yl acetate

C34H48O9S (632.3019)

(1r,4ar,5r,7s,8ar)-5-{[(1r,4ar,8as)-8a-(5,7-dihydroxy-4-oxochromen-2-yl)-6-methoxy-2-methyl-5,8-dioxo-4,4a-dihydro-1h-naphthalen-1-yl]methyl}-7-hydroxy-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C36H40O10 (632.2621)

methyl (1r,2s,7r,8s,9s)-8-[(2s)-2-[(2s,3s,4s,5s)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-2,8-dimethyl-10-oxo-11-oxatricyclo[7.2.1.0²,⁷]dodec-3-ene-3-carboxylate

C29H44O15 (632.268)

(4s)-4-[(2r,4ar,6r)-6-(5-bromo-2,6,6-trimethyloxan-2-yl)-4a,6,8a-trimethyl-tetrahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol

C32H57BrO7 (632.3287)

1-(3,5-dimethyl-6-phenylhex-3-en-1-yl)-6-[(4,6-dimethyloct-2-enoyl)oxy]-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C33H44O12 (632.2833)

(1s,2r,6r,7r,10r,11s,12s,14s,15s,16r,18r)-14-(acetyloxy)-6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-18-yl 2-methylpropanoate

C33H44O12 (632.2833)

(1ar,3s,3ar,4r,5r,6r,7as)-5-(acetyloxy)-3-(furan-3-yl)-6-[(3r,4r)-3-(2-methoxy-2-oxoethyl)-2,2,4-trimethyl-7-oxo-3h-oxepin-4-yl]-3a-methyl-7-methylidene-hexahydroindeno[1,7a-b]oxiren-4-yl benzoate

C36H40O10 (632.2621)

(1r,2r,7r,10r,11s,14r,15s,16r)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-15-hydroxy-10,14,16-trimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadec-4-en-9-one

C34H48O11 (632.3196)

(1s,2r,6r,8r,10r,11s,12s,15r,16s)-15-hydroxy-2,16-dimethyl-5-oxo-15-[(1r)-1-[(3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-3-en-10-yl acetate

C34H48O9S (632.3019)

methyl (1r,4s,5r,6s,7r,8s,10r,15s,16r,18s,19r,22r,23r,26r)-7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-23-{[(2e)-2-methylbut-2-enoyl]oxy}-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C33H44O12 (632.2833)

(1s,2s,4s,5r,6r,7s,9r,12r)-6-[(acetyloxy)methyl]-5-(furan-3-carbonyloxy)-2,12-dihydroxy-2,10,10-trimethyl-4-{[(2r)-2-methylbutanoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl furan-3-carboxylate

C32H40O13 (632.2469)

(1s,3r,5r,6as,7s,8s,9r,10s,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-9,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

methyl (1s,2r,4s,6s,7r,8r,9r,10r,11s,12s,14r,15s,16r,18r)-8,12,18-tris(acetyloxy)-6-(furan-3-yl)-9,14-dihydroxy-1,7,11,15-tetramethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecane-15-carboxylate

C33H44O12 (632.2833)

(2s,3s,4r,4as,4br,7r,8ar,9r,10as)-9-(acetyloxy)-4-(benzoyloxy)-7-ethenyl-3,8a-dihydroxy-1,1,4a,7-tetramethyl-5,8-dioxo-octahydrophenanthren-2-yl benzoate

C36H40O10 (632.2621)

[(2r,3r,4s,5s,6r)-3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-2-[(2e,6e,9s)-9-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-5-methylphenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

methyl (1r,4s,5r,6s,7r,8s,10s,14s,15s,16r,18s,19r,22r,23r,26r)-7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-23-{[(2e)-2-methylbut-2-enoyl]oxy}-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C33H44O12 (632.2833)

21-(acetyloxy)-6-(furan-3-yl)-4,12,19,20-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate

C33H44O12 (632.2833)

5-[1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-8-(benzoyloxy)-6-hydroxy-5,6-dimethyl-hexahydrospiro[naphthalene-1,2'-oxiran]-8a-ylmethyl benzoate

C36H40O10 (632.2621)

methyl 8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-2,8-dimethyl-10-oxo-11-oxatricyclo[7.2.1.0²,⁷]dodec-3-ene-3-carboxylate

C29H44O15 (632.268)

methyl (1r,4s,5r,6s,7r,8s,10r,14r,15s,16r,18s,19r,22r,23r,26r)-7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-23-{[(2e)-2-methylbut-2-enoyl]oxy}-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C33H44O12 (632.2833)

3,16-dihydroxy-4,5,14,15-tetramethoxy-9,10-dimethyl-11-[(3-phenylprop-2-enoyl)oxy]tricyclo[10.4.0.0²,⁷]hexadeca-1(12),2,4,6,13,15-hexaen-8-yl 2-methylbut-2-enoate

C36H40O10 (632.2621)

13-hydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6,14-dihydro-5,11-dioxapentaphene-1,3,7,9-tetrone

C38H48O8 (632.3349)

(2r)-n-[(2r)-1-[(2s,3ar,5s,6s,7as)-2-{[2-(1-carbamimidoyl-2,5-dihydropyrrol-3-yl)ethyl]carbamoyl}-5,6-dihydroxy-octahydroindol-1-yl]-4-methyl-1-oxopentan-2-yl]-2-methoxy-3-(sulfooxy)propanimidic acid

C26H44N6O10S (632.2839)

(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-5-[(2s)-2-{[(2r)-2-methylbutanoyl]oxy}-2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)